3,5--4- cas870718-11-9
l(f)r(sh)g2022-03-30 3,5-Difluoro-4-formylphenylboronic acid ʽ C6H2F2CHOB(OH)2 185.92
؛̖ | Ҏ(gu) | (sh) | r(ji) |
---|---|---|---|
Q-0057079 | 100mg |
1
|
ԃr(ji) |
Q-0057079 | 250mg |
1
|
ԃr(ji) |
Q-0057079 | 500mg |
1
|
ԃr(ji) |
Q-0057079 | 1g |
1
|
ԃr(ji) |
Q-0057079 | 5g |
1
|
ԃr(ji) |
ӆُ/bԃ
N۽(jng)

I(y)(w)ЙC(j) | Ӳ | ٴ | | {a(chn)Ʒ
ԓa(chn)Ʒa(chn)ۺ}Ո(lin)ϵ҂
a(chn)ƷB
3,5--4-
cas870718-11-9
3,5-Difluoro-4-formylphenylboronic acid
ʽ C6H2F2CHOB(OH)2
185.92
P(gun)a(chn)Ʒ
Pomalidomide CAS:19171-19-8 | pgӹٷ |
4-Fluoro-thalidomide CAS:835616-60-9 | pgӹٷ |
Thalidomide-O-PEG5-Tosyl CAS:2414905-34-1 | pgӹٷ |
Thalidomide-O-PEG4-t-butyl ester CAS:2411681-87-1 | pgӹٷ |
Thalidomide-O-amido-PEG4-propargyl CAS:2411681-90-6 | pgӹٷ |
Thalidomide-O-PEG4-Propargyl CAS:2098799-77-8 | pgӹٷ |
;{dw
SңpgӹٷƼ˾
؛ڣF(xin)؛
ͣSfT
;
B(ti)w/ĩ
a(chn)أ
(ch)r(sh)g1

(sh)Ϣ | |
---|---|
^B(ti) | wĩ |
|(zh)ָ(bio) | 95%+ |
ܽl | ЙC(j)܄/ˮ |
CAS̖ | N/A |
N/A | |
(ch)l | -20ܹⱣ |
(ch)r(sh)g | 1 |
\(yn)ݔl | Ҝ2 |
a(chn)Sң | pgӹٷƼ˾ |
P(gun)a(chn)Ʒ
-
DSPE-PEG-FA һN͵İ֬-ҶPEGPEGĩ~ᣨFolic Acid, FAԓϽY(ji)DSPE֬PEGLHˮԾۺFAСӰwă(yu)c(din)߂õHˮԡԺ[
-
ӢCy5-PEG-NH? s2000 Da CY5-PEG2K-NH2Cy5(bio)ӛPEGľҶA(ch)һ˘(bio)ӛCy5ɹȾһ˱CNH?܈F(tun)Cy5һNtɹȾl(f)䲨Ls670 nmеͱ(qing)̖ⷀ(wn)c(din)
-
l(f)r(sh)g2022-03-30 DSPE-Ҷ- PEG:2000;3000;5000 DSPE-PEG-c-dGHCitGPQ-c
-
l(f)r(sh)g2022-03-30 DSPE-PEG-VRPMPLQӲ֬֬Ҵ-Ҷ-) PEG:2000;3000;5000 DSPE-PEG-VRPMPLQ